DuPont de Nemours: The Right Chemistry

7/15/20

By Michael A. Gayed, CFA, SeekingAlpha

There is great news for DuPont de Nemours (NYSE:DD) shareholders - Wells Fargo has recently confirmed its Overweight rating and raised its price target to $65. RBC Capital also has upgraded the stock from Sector Performer to Outperformer and raised its target price to $66. This is bullish news in a market that is trending higher week after week.

Though DD faces many challenges in 2020-21 because of the COVID-19 disruption, its management team has moved swiftly to ensure that the company can easily handle whatever comes its way. Based on the following two factors - (A) company's swift and efficient handling of the virus disruption and minimizing its impact and (B) company's profitability - I am bullish on the stock. Here are my reasons.

READ FULL ARTICLE HERE